Klaus F. Rabe
About
Klaus F. Rabe is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology.
According to data from OpenAlex, Klaus F. Rabe has authored 585 papers receiving a total of 37.6k indexed citations (citations by other indexed papers that have themselves been cited), including 411 papers in Pulmonary and Respiratory Medicine, 314 papers in Physiology and 60 papers in Immunology. Recurrent topics in Klaus F. Rabe's work include Asthma and respiratory diseases (302 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (240 papers) and Respiratory and Cough-Related Research (125 papers). Klaus F. Rabe is often cited by papers focused on Asthma and respiratory diseases (302 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (240 papers) and Respiratory and Cough-Related Research (125 papers). Klaus F. Rabe collaborates with scholars based in Germany, Netherlands and United States. Klaus F. Rabe's co-authors include Leonardo M. Fabbri, Peter M.A. Calverley, Pieter S. Hiemstra, Peter J. Barnes, Henrik Watz, Antonio Anzueto, Martin Reck, H Magnussen, Romain Pauwels and Christine Jenkins and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.
In The Last Decade
Klaus F. Rabe
554 papers receiving 36.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Klaus F. Rabe Germany | 91 | 25.9k | 18.2k | 4.6k | 3.5k | 2.3k | 585 | 37.6k | ||
| Leonardo M. Fabbri Italy | 95 | 27.9k 1.1× | 19.0k 1.0× | 3.0k 0.6× | 3.4k 0.9× | 3.1k 1.3× | 487 | 39.5k | ||
| Dirkje S. Postma Netherlands | 89 | 18.8k 0.7× | 16.6k 0.9× | 4.0k 0.9× | 3.5k 1.0× | 2.5k 1.1× | 592 | 31.2k | ||
| Stephen I. Rennard United States | 93 | 20.5k 0.8× | 12.3k 0.7× | 6.9k 1.5× | 2.7k 0.8× | 1.7k 0.7× | 594 | 35.7k | ||
| Scott T. Weiss United States | 111 | 16.2k 0.6× | 22.8k 1.3× | 6.1k 1.3× | 4.2k 1.2× | 3.0k 1.3× | 767 | 43.3k | ||
| Guy Brusselle Belgium | 79 | 12.5k 0.5× | 12.1k 0.7× | 2.6k 0.6× | 4.3k 1.2× | 1.8k 0.8× | 445 | 22.8k | ||
| Alberto Papi Italy | 79 | 14.1k 0.5× | 12.5k 0.7× | 1.9k 0.4× | 4.2k 1.2× | 2.5k 1.1× | 501 | 22.7k | ||
| Jeffrey M. Drazen United States | 89 | 12.6k 0.5× | 17.4k 1.0× | 4.2k 0.9× | 4.6k 1.3× | 1.2k 0.5× | 427 | 30.1k | ||
| Edwin K. Silverman United States | 85 | 19.2k 0.7× | 9.8k 0.5× | 3.8k 0.8× | 2.0k 0.6× | 2.2k 1.0× | 484 | 27.3k | ||
| Ian M. Adcock United Kingdom | 100 | 12.6k 0.5× | 13.1k 0.7× | 11.6k 2.5× | 8.6k 2.4× | 2.7k 1.2× | 645 | 36.4k | ||
| Peter G. Gibson Australia | 116 | 22.0k 0.9× | 29.2k 1.6× | 5.8k 1.3× | 7.6k 2.1× | 3.7k 1.6× | 1.0k | 53.2k |
Countries citing papers authored by Klaus F. Rabe
Since
Specialization
Citations
This map shows the geographic impact of Klaus F. Rabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus F. Rabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus F. Rabe more than expected).
Fields of papers citing papers by Klaus F. Rabe
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Klaus F. Rabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus F. Rabe. The network helps show where Klaus F. Rabe may publish in the future.
Co-authorship network of co-authors of Klaus F. Rabe
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus F. Rabe. A scholar is included among the top collaborators of Klaus F. Rabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus F. Rabe. Klaus F. Rabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Omony, Jimmy, Clemens Thölken, Azam Salimi, et al.. (2024). Urinary eosinophil‐derived neurotoxin is associated with reduced lung function in pediatric asthma. Pediatric Allergy and Immunology. 35(6). e14172–e14172.
2.
Bhatt, Surya P., Klaus F. Rabe, Nicola A. Hanania, et al.. (2024). Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS). Respiratory Medicine. 236. 107846–107846.
3.
Alter, Peter, Kathrin Kahnert, Franziska Trudzinski, et al.. (2024). Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET. International Journal of COPD. Volume 19. 2629–2638.
4.
Kahnert, Kathrin, Rudolf A. Jörres, Hans‐Ulrich Kauczor, et al.. (2023). Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic Advances in Respiratory Disease. 17. 2673727991–2673727991.
5.
Singh, Dave, John R. Hurst, Fernando J. Martínez, et al.. (2022). Predictive modeling of COPD exacerbation rates using baseline risk factors. Therapeutic Advances in Respiratory Disease. 16. 2673686642–2673686642.
6.
Ichinose, Masakazu, Yasushi Fukushima, Yoshikazu Inoue, et al.. (2019). <p>Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD</p>. International Journal of COPD. Volume 14. 2993–3002.
7.
Busse, William W., Eric D. Bateman, Arthur L. Caplan, et al.. (2018). Combined Analysis of Asthma Safety Trials of Long-Acting β 2 -Agonists. New England Journal of Medicine. 378(26). 2497–2505.
8.
Marwitz, Sebastian, Sofia Depner, Karin Müller‐Decker, et al.. (2016). Downregulation of the TGFβ Pseudoreceptor BAMBI in Non–Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion. Cancer Research. 76(13). 3785–3801.
9.
Beghé, Bianca, Klaus F. Rabe, & Leonardo M. Fabbri. (2013). Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases. American Journal of Respiratory and Critical Care Medicine. 188(3). 271–278.
10.
Kunz, Lisette I.Z., Thérèse Lapperre, Jiska B. Snoeck-Stroband, et al.. (2011). Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Respiratory Research. 12(1). 34–34.
11.
Han, MeiLan K., Àlvar Agustí, Peter M.A. Calverley, et al.. (2010). Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD. American Journal of Respiratory and Critical Care Medicine. 182(5). 598–604.
12.
Wenzel, Sally E., Peter J. Barnes, Eugene R. Bleecker, et al.. (2009). A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma. American Journal of Respiratory and Critical Care Medicine. 179(7). 549–558.
13.
Veen, Ilonka H. van, Anneke Ten Brinke, Peter Sterk, Klaus F. Rabe, & Elisabeth H. Bel. (2008). Airway inflammation in obese and nonobese patients with difficult‐to‐treat asthma. Allergy. 63(5). 570–574.
14.
Brinke, Anneke Ten, Aeilko H. Zwinderman, Peter Sterk, Klaus F. Rabe, & Elisabeth H. Bel. (2004). “Refractory” Eosinophilic Airway Inflammation in Severe Asthma. American Journal of Respiratory and Critical Care Medicine. 170(6). 601–605.
15.
Sont, Jacob K., Jasmijn A. Schrumpf, Claire R. Dick, et al.. (2003). Are Rhinovirus-induced Airway Responses in Asthma Aggravated by Chronic Allergen Exposure?. American Journal of Respiratory and Critical Care Medicine. 168(10). 1174–1180.
16.
Brinke, Anneke Ten, Aeilko H. Zwinderman, Peter Sterk, Klaus F. Rabe, & Elisabeth H. Bel. (2001). Factors Associated with Persistent Airflow Limitation in Severe Asthma. American Journal of Respiratory and Critical Care Medicine. 164(5). 744–748.
17.
Brinke, Anneke Ten, et al.. (2001). Sputum Induction in Severe Asthma by a Standardized Protocol. American Journal of Respiratory and Critical Care Medicine. 164(5). 749–753.
18.
Schmidt, D. & Klaus F. Rabe. (2000). The Role of Leukotrienes in the Regulation of Tone and Responsiveness in Isolated Human Airways. American Journal of Respiratory and Critical Care Medicine. 161(Supplement_1). S62–S67.
19.
Rabe, Klaus F.. (1998). Mechanisms of Immune Sensitization of Human Bronchus. American Journal of Respiratory and Critical Care Medicine. 158(Supplement_2). S161–S170.
20.
Rabe, Klaus F., N. Watson, Gordon Dent, et al.. (1998). Inhibition of Human Airway Sensitization by a Novel Monoclonal Anti-IgE Antibody, 17-9. American Journal of Respiratory and Critical Care Medicine. 157(5). 1429–1435.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Leonardo M. Fabbri Breakdown of academic impact, for papers by Dirkje S. Postma Breakdown of academic impact, for papers by Stephen I. Rennard Breakdown of academic impact, for papers by Scott T. Weiss Breakdown of academic impact, for papers by Guy Brusselle Breakdown of academic impact, for papers by Alberto Papi Breakdown of academic impact, for papers by Jeffrey M. Drazen Breakdown of academic impact, for papers by Edwin K. Silverman Breakdown of academic impact, for papers by Ian M. Adcock Breakdown of academic impact, for papers by Peter G. Gibson